The Stopping Atherosclerosis and Treating Unhealthy Bone With Rosuvastatin in HIV ( SATURN-HIV ) trial randomized 147 patients on stable antiretroviral therapy ( ART ) with low-density lipoprotein cholesterol 130 mg/dL to blinded 10 mg daily rosuvastatin or placebo .